Advances in anticancer radiopharmaceuticals.
This review highlights recent progress in the development of anticancer radiopharmaceuticals. Molecularly targeted radiotherapy refers to the selective delivery of radionuclides that emit charged particles, such as α particles, β or Auger electrons, to cancer cells via a targeting vector. The discov...
主要な著者: | Jackson, MR, Falzone, N, Vallis, K |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2013
|
類似資料
-
Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical
著者:: Cornelissen, B, 等
出版事項: (2012) -
Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical.
著者:: Cornelissen, B, 等
出版事項: (2012) -
Targeted radionuclide therapy: new advances for improvement of patient management and response
著者:: Malcolm, J, 等
出版事項: (2019) -
Radiopharmaceuticals for imaging and therapy.
著者:: Faulkner, S, 等
出版事項: (2011) -
Regulation of Radiopharmaceutical Products
著者:: V. V. Kosenko, 等
出版事項: (2022-12-01)